Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Sofie Møller Lumholtz ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.0% 1.0% 2.2% 2.2% 3.0% 1.4% 5.9% 5.9%   Credit score (0-100)   70 88 66 64 57 77 39 39   Credit rating   A A BBB BBB BBB A BBB BBB   Credit limit (kDKK)   0.5 282.0 0.1 0.1 0.0 39.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,116 9,383 8,480 9,304 10,158 12,181 0.0 0.0   EBITDA   1,421 1,711 855 995 811 1,865 0.0 0.0   EBIT   914 1,191 310 416 -161 806 0.0 0.0   Pre-tax profit (PTP)   418.9 713.1 11.1 102.1 -827.0 158.8 0.0 0.0   Net earnings   322.4 552.1 4.2 84.0 -608.1 150.5 0.0 0.0   Pre-tax profit without non-rec. items   419 713 11.1 102 -827 159 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,597 1,465 1,227 1,865 5,071 4,461 0.0 0.0   Shareholders equity total   1,453 1,897 1,790 1,761 1,039 1,189 1,017 1,017   Interest-bearing liabilities   1,360 2,888 913 380 4,507 4,797 1,791 1,791   Balance sheet total (assets)   8,078 7,930 7,016 7,363 10,308 9,838 2,808 2,808   Net Debt   884 2,264 741 314 4,435 4,415 1,791 1,791     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,116 9,383 8,480 9,304 10,158 12,181 0.0 0.0   Gross profit growth   1.4% 15.6% -9.6% 9.7% 9.2% 19.9% -100.0% 0.0%   Employees   13 13 13 14 17 18 0 0   Employee growth %   0.0% 0.0% 0.0% 7.7% 21.4% 5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,078 7,930 7,016 7,363 10,308 9,838 2,808 2,808   Balance sheet change%   -6.0% -1.8% -11.5% 4.9% 40.0% -4.6% -71.5% 0.0%   Added value   1,421.4 1,711.0 854.7 995.4 418.2 1,864.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,016 -897 -1,028 -186 1,988 -1,914 -6,181 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.3% 12.7% 3.7% 4.5% -1.6% 6.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.0% 14.9% 4.2% 5.8% -1.8% 8.0% 0.0% 0.0%   ROI %   19.7% 27.3% 7.1% 13.9% -3.7% 13.1% 0.0% 0.0%   ROE %   24.0% 33.0% 0.2% 4.7% -43.4% 13.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.1% 24.0% 25.6% 24.1% 10.1% 12.1% 36.2% 36.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   62.2% 132.3% 86.7% 31.5% 546.8% 236.8% 0.0% 0.0%   Gearing %   93.6% 152.3% 51.0% 21.6% 433.8% 403.3% 176.0% 176.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   17.1% 22.6% 15.8% 48.9% 27.3% 13.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0   Current Ratio   0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0   Cash and cash equivalent   476.5 624.2 172.3 65.9 71.9 381.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,362.1 -1,799.4 -3,910.1 -4,629.8 -8,531.8 -7,518.1 -895.3 -895.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   109 132 66 71 25 104 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   109 132 66 71 48 104 0 0   EBIT / employee   70 92 24 30 -9 45 0 0   Net earnings / employee   25 42 0 6 -36 8 0 0